Economic portfolio
HDFC Pharma and Healthcare Fund
HDFC HDFC Mutual Fund Aug 2026 — Sep 2026 2 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 6.4 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Takes days, not hours, to unwind. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 25 shared62.6%
- Bandhan BSE Healthcare Index FundBandhan · 35 shared61.1%
- Motilal Oswal BSE Healthcare ETFMotilal Oswal · 35 shared61.1%
- Mirae Asset Healthcare FundMirae Asset · 20 shared60.9%
- EODWHFEdelweiss · 18 shared57.0%
- UTI - Healthcare FundUTI · 23 shared56.1%
- WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital · 23 shared55.6%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 15 shared55.1%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
Largest increases
- 01 Dr. Reddy's Laboratories Limited+66.1% +3.60 L
- 02 Cipla Limited+16.8% +1.55 L
- 03 Jupiter Life Line Hospitals Limited+6.9% +1.49 L
- 04 Alkem Laboratories Limited+65.9% +1.25 L
- 05 Apollo Hospitals Enterprise Limited+206.0% +1.06 L
- 06 Aster DM Quality Care Limited+6.2% +1.05 L
- 07 Sun Pharmaceutical Industries Limited+6.9% +1.04 L
- 08 Gland Pharma Limited+71.7% +89,744
- 09 Max Healthcare Institute Limited+5.5% +71,000
- 10 Global Health Limited+9.5% +60,329
Largest reductions
- None this month.
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Divi's Laboratories Limited | Healthcare | Large Cap | 9.70% | 329 Cr | 0.04 Cr | by Aug 2026 (2 mo+) |
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 8.55% | 290 Cr | 0.16 Cr | by Aug 2026 (2 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 4.80% | 163 Cr | 0.03 Cr | by Aug 2026 (2 mo+) |
| Cipla Limited | Healthcare | Large Cap | 4.29% | 145 Cr | 0.11 Cr | by Aug 2026 (2 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 3.81% | 129 Cr | 0.02 Cr | by Aug 2026 (2 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 3.78% | 128 Cr | 0.03 Cr | by Aug 2026 (2 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 3.73% | 126 Cr | 0.14 Cr | by Aug 2026 (2 mo+) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 3.67% | 125 Cr | 0.18 Cr | by Aug 2026 (2 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 3.66% | 124 Cr | 0.06 Cr | by Aug 2026 (2 mo+) |
| Neuland Laboratories Limited | Healthcare | Small Cap | 3.35% | 114 Cr | 53,164 | by Aug 2026 (2 mo+) |
| Shilpa Medicare Limited | Healthcare | Small Cap | 3.34% | 113 Cr | 0.11 Cr | by Aug 2026 (2 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 3.29% | 112 Cr | 0.09 Cr | by Aug 2026 (2 mo+) |
| Acutaas Chemicals Limited | Healthcare | Small Cap | 3.28% | 111 Cr | 0.03 Cr | by Aug 2026 (2 mo+) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 3.27% | 111 Cr | 0.13 Cr | by Aug 2026 (2 mo+) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 3.08% | 104 Cr | 0.05 Cr | by Aug 2026 (2 mo+) |
| Global Health Limited | Healthcare | Mid Cap | 2.81% | 95.30 Cr | 0.07 Cr | by Aug 2026 (2 mo+) |
| Rubicon Research Limited | Healthcare | Small Cap | 2.60% | 88.16 Cr | 0.05 Cr | by Aug 2026 (2 mo+) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 2.17% | 73.50 Cr | 0.10 Cr | by Aug 2026 (2 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 2.16% | 73.05 Cr | 0.03 Cr | by Aug 2026 (2 mo+) |
| Molbio Diagnostics Limited | Not classified | — | 2.08% | 70.42 Cr | 0.05 Cr | by Aug 2026 (2 mo+) |
| Vijaya Diagnostic Centre Limited | Healthcare | Small Cap | 2.07% | 70.17 Cr | 0.05 Cr | by Aug 2026 (2 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 1.88% | 63.78 Cr | 0.05 Cr | by Aug 2026 (2 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 1.84% | 62.32 Cr | 0.02 Cr | by Aug 2026 (2 mo+) |
| Wockhardt Limited | Healthcare | Small Cap | 1.77% | 59.95 Cr | 0.03 Cr | by Aug 2026 (2 mo+) |
| Jupiter Life Line Hospitals Limited | Not classified | Small Cap | 1.74% | 58.95 Cr | 0.23 Cr | by Aug 2026 (2 mo+) |
| Metropolis Healthcare Limited | Healthcare | Small Cap | 1.73% | 58.58 Cr | 0.11 Cr | by Aug 2026 (2 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 1.63% | 55.18 Cr | 0.04 Cr | by Aug 2026 (2 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 1.52% | 51.49 Cr | 0.14 Cr | by Aug 2026 (2 mo+) |
| Symbiotec Pharmalab Limited | Not classified | — | 1.41% | 47.64 Cr | 0.04 Cr | by Aug 2026 (2 mo+) |
| Thyrocare Technologies Limited | Healthcare | Small Cap | 1.13% | 38.41 Cr | 0.07 Cr | by Aug 2026 (2 mo+) |
| CORONA Remedies Limited | Not classified | Small Cap | 1.07% | 36.29 Cr | 0.02 Cr | by Aug 2026 (2 mo+) |
| Entero Healthcare Solutions Limited | Consumer Services | Small Cap | 1.04% | 35.37 Cr | 0.02 Cr | Sep 2026 (1 mo) |
| Jubilant Pharmova Limited | Healthcare | Small Cap | 0.96% | 32.67 Cr | 0.03 Cr | by Aug 2026 (2 mo+) |
| Eris Lifesciences Limited | Healthcare | Small Cap | 0.95% | 32.34 Cr | 0.03 Cr | by Aug 2026 (2 mo+) |
| Novartis India Limited | Not classified | Small Cap | 0.57% | 19.31 Cr | 0.01 Cr | by Aug 2026 (2 mo+) |
| Bajaj Healthcare Limited | Not classified | Small Cap | 0.55% | 18.61 Cr | 0.06 Cr | by Aug 2026 (2 mo+) |
| Laxmi Dental Limited | Not classified | Small Cap | 0.36% | 12.34 Cr | 0.06 Cr | by Aug 2026 (2 mo+) |
| Cohance Lifesciences Limited | Healthcare | Small Cap | 0.33% | 11.10 Cr | 0.03 Cr | by Aug 2026 (2 mo+) |
Half of its current holdings have been held for 2 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Fortis Healthcare Limited | Sep 2026 | ▼ Complete exit | -0.09 Cr |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▲ Increasing | +0.04 Cr |
| Entero Healthcare Solutions Limited | Sep 2026 | ▲ New position | +0.02 Cr |
| Cipla Limited | Sep 2026 | ▲ Increasing | +0.02 Cr |
| Jupiter Life Line Hospitals Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Ajanta Pharma Limited | Sep 2026 | ▼ Complete exit | -0.01 Cr |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Aster DM Quality Care Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▲ Increasing | +0.01 Cr |
| Gland Pharma Limited | Sep 2026 | ▲ Increasing | +89,744 |
| Max Healthcare Institute Limited | Sep 2026 | ▲ Increasing | +71,000 |
| Global Health Limited | Sep 2026 | ▲ Increasing | +60,329 |
| Rubicon Research Limited | Sep 2026 | ▲ Increasing | +31,687 |
| Divi's Laboratories Limited | Sep 2026 | ▲ Increasing | +20,000 |
Changes compare consecutive month-end disclosures for this portfolio only.